Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 1999, p. 1200-1202, Vol. 37, No. 4
Universität Tuebingen,
Received 31 August 1998/Returned for modification 2 November
1998/Accepted 18 December 1998
Successful in vitro amplification of fungal DNA in clinical
specimens has been reported recently. In a collaboration among five
European centers, the frequency and risk of contamination due to
airborne spore inoculation or carryover contamination in fungal PCR
were analyzed. The identities of all contaminants were specified by
cycle sequencing and GenBank analysis. Twelve of 150 PCR assays that
together included over 2,800 samples were found to be contaminated
(3.3% of the negative controls were contaminated during the DNA
extraction, and 4.7% of the PCR mixtures were contaminated during the
amplification process). Contaminants were specified as
Aspergillus fumigatus, Saccharomyces
cerevisiae, and Acremonium spp. Further analysis
showed that commercially available products like zymolyase powder or
10× PCR buffer may contain fungal DNA. In conclusion, the risk of
contamination is not higher in fungal PCR assays than in other
diagnostic PCR-based assays if general precautions are taken.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Contaminations Occurring in Fungal PCR
Assays
*
Corresponding author. Mailing address: Medizinische
Klinik, Abt. II, Labor Dr. Einsele, Otfried-Mueller-Str. 10, 72076 Tuebingen, Germany. Phone: 49 7071 2987355. Fax: 49 7071 293179. E-mail: juergenloeffler{at}med.uni-tuebingen.de.
Journal of Clinical Microbiology, April 1999, p. 1200-1202, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|